A 12 Week, Multicenter, Open Label Evaluation of Caregiver Preference, Safety and Tolerability of Exelon® Patch (Rivastigmine Transdermal) in Patients With Alzheimer's Disease
Clinical trial NCT01047579 · COMPLETED
Trial details
- NCT number
- NCT01047579
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2012-01-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.